Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
24637 | 256 | 34.2 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1408 | 7561 | ATRIAL NATRIURETIC PEPTIDE//C TYPE NATRIURETIC PEPTIDE//ATRIAL NATRIURETIC FACTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CARDIAC HORMONE | Address | 81 | 83% | 18% | 45 |
2 | VESSEL DILATOR | Author keyword | 17 | 100% | 3% | 8 |
3 | KALIURETIC PEPTIDE | Author keyword | 15 | 88% | 3% | 7 |
4 | CARDIAC HORMONES | Author keyword | 14 | 57% | 6% | 16 |
5 | ATRIAL NATRIURET PEPTIDES S | Address | 11 | 100% | 2% | 6 |
6 | ATRIAL NATRIURETIC FACTOR PROHORMONE | Author keyword | 8 | 75% | 2% | 6 |
7 | PLANT NATRIURETIC PEPTIDES | Author keyword | 6 | 80% | 2% | 4 |
8 | PROHORMONE ATRIAL NATRIURETIC PEPTIDES | Author keyword | 6 | 100% | 2% | 4 |
9 | ATRIAL NATRIURETIC PEPTIDES | Author keyword | 4 | 20% | 8% | 20 |
10 | USF CARDIAC HORMONE | Address | 4 | 75% | 1% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VESSEL DILATOR | 106 | 95% | 14% | 36 |
2 | 3 PEPTIDES | 75 | 91% | 12% | 31 |
3 | FACTOR PROHORMONE | 73 | 68% | 25% | 64 |
4 | KALIURETIC PEPTIDE | 41 | 87% | 8% | 20 |
5 | PEPTIDES 1 30 | 37 | 100% | 5% | 14 |
6 | CIRCULATE | 37 | 65% | 14% | 35 |
7 | INHIBIT MEK 1 2 ACTIVATION | 33 | 100% | 5% | 13 |
8 | C TERMINAL PORTIONS | 29 | 88% | 5% | 14 |
9 | INDUCED CENTRAL HYPERVOLEMIA | 27 | 78% | 7% | 18 |
10 | 31 67 INCREASE | 27 | 92% | 4% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer? | 2006 | 26 | 56 | 48% |
New Anticancer Agents: Hormones Made within the Heart | 2012 | 3 | 55 | 69% |
Metabolic Targets of Cardiac Hormones' Therapeutic Anti-Cancer Effects | 2010 | 5 | 72 | 56% |
Natriuretic Peptides' Metabolic Targets for Treatment of Cancer | 2013 | 2 | 93 | 45% |
Family of Peptides Synthesized in the Human Body Have Anticancer Effects | 2014 | 1 | 99 | 37% |
Natriuretic peptides and acute renal failure | 2003 | 53 | 113 | 29% |
Atrial natriuretic peptide prohormone gene expression: Hormones and diseases that upregulate its expression | 2002 | 37 | 35 | 34% |
Cardiac natriuretic peptides: hormones with anticancer effects that localize to nucleus, cytoplasm, endothelium, and fibroblasts of human cancers | 2006 | 6 | 57 | 65% |
Cardiac hormones for the treatment of cancer | 2013 | 0 | 130 | 38% |
Evolutionary advantages of secreted peptide signalling molecules in plants | 2010 | 7 | 99 | 13% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CARDIAC HORMONE | 81 | 83% | 18% | 45 |
2 | ATRIAL NATRIURET PEPTIDES S | 11 | 100% | 2.3% | 6 |
3 | USF CARDIAC HORMONE | 4 | 75% | 1.2% | 3 |
4 | JA HALEY VET MED | 3 | 100% | 1.2% | 3 |
5 | JAMES A HALEY VA MED | 2 | 43% | 1.2% | 3 |
6 | HLTH SCI CARDIAC HORMONE | 1 | 100% | 0.8% | 2 |
7 | JA HALEY VET MED 151 | 1 | 100% | 0.8% | 2 |
8 | HLTH SCI BIOPHYS | 1 | 40% | 0.8% | 2 |
9 | MED DIAGNOST SCI SPECIAL THER Y | 1 | 50% | 0.4% | 1 |
10 | MED MOL PHARMACOL PHYSIOL | 1 | 50% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000224821 | ATRIAL NATRIURETIC PEPTIDE//ATRIAL NATRIURETIC FACTOR//110 PINE AVE W |
2 | 0.0000148745 | C TYPE NATRIURETIC PEPTIDE//NATRIURETIC PEPTIDE RECEPTOR//ATRIAL NATRIURETIC PEPTIDE |
3 | 0.0000147328 | PHYTOSULFOKINE//BIOACT NAT PROD CHEM//PHYTOSULFOKINE ALPHA |
4 | 0.0000087629 | CNGC//CYCLIC CMP//CYCLIC NUCLEOTIDE GATED ION CHANNEL |
5 | 0.0000074084 | RECTAL GLAND//VENTRICULAR NATRIURETIC PEPTIDE//NATRIURETIC PEPTIDE FAMILY |
6 | 0.0000069512 | METAL IMBALANCE//INDUCTION MAINTENANCE THERAPY//TPIRC |
7 | 0.0000053821 | GLUTEIN//MNU N METHYL N NITROSOUREA//RUNNING ACTIVITY |
8 | 0.0000053394 | CU GNRH//GRP MED PHARMACOL TOXICOL//GRP GYNAECOL ONCOL |
9 | 0.0000052292 | BOVINE BRONCHI//SHORT ACTING BRONCHODILATORS//TRACHEAL SMOOTH MUSCLE RELAXATION |
10 | 0.0000051916 | FDN CARDIOL//FISIOL TRANSLAC//TRANSLAT PHYSIOL |